The clinical nurse specialist was also diagnosed with stage III invasive lobular breast cancer and was treated with CDK 4/6 inhibitors, giving her the unique opportunity to speak to both the patient and clinical perspective.
Patricia Jakel, RN, MN, AOCN
Advertisement
Articles by Patricia Jakel, RN, MN, AOCN
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Melanoma Trials You May Have Missed at ASCO 2026
2
Daraxonrasib/Vopimetostat Yield Stunning Response Rate in MTAP-del Pancreatic Cancer
3
77 Updated Efficacy of Mutant-Selective PI3Kα Inhibitor Zovegalisib (RLY-2608) in Combination With Fulvestrant in Patients With PIK3CA-Mutant HR+/HER2– Advanced Breast Cancer: ReDiscover Trial
4
Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC
5